Verstockt B, Vermeire S, Peyrin-Biroulet L, Mosig R, et al. The Safety, Tolerability, Pharmacokinetics and Clinical Efficacy of the NLRX1 agonist NX-13 in Active Ulcerative Colitis: Results of a Phase 1b Study. J Crohns Colitis 2023 Nov 11:jjad192. doi: 10.1093.
PMID: 37952114